David Goldstein

I started my PhD work in 1990, which was exactly when the Human Genome Project was being designed. Throughout my entire professional life folks like me have been promising that we are going to transform medicine with genetics. And I resisted the idea – nobody wants to overpromise – but we’ve made so much progress, so much unforeseen progress even, that I cannot resist anymore. 

We really are on the precipice of changing medicine in so many ways – we can quickly and accurately identify all the changes in someone’s genome right now. Sometimes we’re looking for the change of a single letter, a single mutation, that’s responsible for your disease – and now we can do that. We can find it. And we can intervene – we can edit a genomic mutation that causes a disease.  And we can create a targeted compound to fight the disease that that mutation causes. It’s already happening, especially in epilepsy, in psychiatry, and it’s showing great promise in cancer. 

And it’s this kind of work, and the support for it across the University, that made me want to come to Columbia. Our commitment to precision medicine is truly extraordinary.